Product Program year 2020 Source: CMS Open Payments

Lorzone

Drug Muscle Relaxant

NDC 68025-047-10

Open in the dashboard

General payments

$45,784

2,933 payments

Research payments

$0

0 payments

Through program year 2020, $45,784 in general payments and $0 in research payments were reported against Lorzone (Muscle Relaxant).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $4,839 302
2019 General $40,945 2,631

Breakdown

Who paid General payments · program years 2019–2020
  1. Vertical Pharmaceuticals, LLC $45,784 2,933 payments
Top recipients General payments · program year 2020
  1. Norman Leopold Neurology · Chester, PA $39 <1% · 2 payments
  2. Pasquale Brancazio Neurology · Chester, PA $39 <1% · 2 payments
  3. Karen Rogers Developmental - Behavioral Pediatrics · Lubbock, TX $35 <1% · 2 payments
  4. Joseph Ciocca Obstetrics & Gynecology · Beaver, PA $35 <1% · 2 payments
  5. Tonya Phillips Neurology · Fort Smith, AR $27 <1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Neurology Psychiatry & Neurology $1,914 41% · 111 practitioners
  2. Obstetrics & Gynecology $1,158 25% · 77 practitioners
  3. Psychiatry Psychiatry & Neurology $465 10% · 30 practitioners
  4. Pediatrics $339 7% · 22 practitioners
  5. Family Medicine $222 5% · 13 practitioners

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Pennsylvania $543 11% · 31 recipients
  2. New York $476 10% · 29 recipients
  3. Texas $366 8% · 18 recipients
  4. Missouri $342 7% · 23 recipients
  5. Colorado $323 7% · 19 recipients

The top 5 of 26 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

2,933 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record